These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13505313)

  • 1. [Effect of N1-sulfanilylo-N2-n-butylcarbamide on course of alloxan diabetes in rabbits and on hyperglycemic factor (glucagon) in pancreatic extracts in dogs].
    CZYZYK A
    Pol Arch Med Wewn; 1957; 27(8):1057-67. PubMed ID: 13505313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of maximal tubular re-resorption for glucose after N1-sulfanilyl-N2-n-butylcarbamide administration in the dog].
    PETROVIC C; PILGRIM C; SUDHOF H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 235(2):96-102. PubMed ID: 13632853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin and glucagon activity of pancreas extracts from dogs treated by BZ-55].
    STAHL J; DORNER M
    Ann Endocrinol (Paris); 1957; 18(2):258-9. PubMed ID: 13458924
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of N-sulfanilyl-N-butylcarbamide on metabolism & growth of transplanted tumors].
    KUNZ W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1957; 232(1):350-1. PubMed ID: 13526892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of N1-sulfanilyl-N2-n-butyl carbamide on the progress of alloxan diabetes in rabbits and on the glucagon content in dogs pancreas].
    CZYZK A
    Arzneimittelforschung; 1956 Dec; 6(12):700-1. PubMed ID: 13395925
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of the treatment of diabetes mellitus on the development of cardiac changes in alloxan diabetes].
    Pog'atsa G; Bihari-Varga M; Szinay G
    Orv Hetil; 1980 Jan; 121(2):91-4. PubMed ID: 6768045
    [No Abstract]   [Full Text] [Related]  

  • 7. [The action of blood glucose lowering sulfonamides on liver metabolism].
    Söling HD
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():396-414. PubMed ID: 4906022
    [No Abstract]   [Full Text] [Related]  

  • 8. Has the new antidiabetic drug, N1-sulphanilyl-N2-N-butylcarbamide goitrogenic properties? An experimental study.
    ANTILA V; KUUSISTO AN
    Acta Endocrinol (Copenh); 1956 Dec; 23(4):433-6. PubMed ID: 13394040
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of carbutamide on blood levels of glucose, potassium and inorganic phosphate; studies of the serum in diabetic and healthy man and pancreatectomized dogs.
    SZUCS S; TISZAI A
    Diabetes; 1958; 7(4):288-92. PubMed ID: 13561862
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic treatment with carbutamide on distribution and biosynthesis of fatty acids and cholesterol in obese-hyperglycemic mice.
    CHRISTOPHE J; MAYER J
    Am J Physiol; 1959 Mar; 196(3):603-6. PubMed ID: 13627232
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
    Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies.
    Black HE; Rosenblum IY; Capen CC
    Am J Pathol; 1980 Feb; 98(2):295-310. PubMed ID: 6444498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic activity of some antidiabetic plants.
    Román Ramos R; Lara Lemus A; Alarcón Aguilar F; Flores Saenz JL
    Arch Med Res; 1992; 23(3):105-9. PubMed ID: 1308798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune and diabetogenic effects of bucarban].
    Zaks AS; Bykova AA; Evteeva TA
    Farmakol Toksikol; 1983; 46(4):79-82. PubMed ID: 6617840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic function in alloxan "subdiabetic" rats long-term treated with tolbutamide.
    WEBER JW; COLOMBO JP; GOLDBERG RI; SAPERSTEIN S; SHULKIND ML; KANAMEISHI D; FOA PP
    Diabetes; 1961; 10():122-9. PubMed ID: 13783629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum protein binding of carbutamide in normal and alloxan diabetic rabbits].
    Imamura Y; Sonoda M; Otagiri M; Ichibagase H
    Yakugaku Zasshi; 1985 Oct; 105(10):1004-7. PubMed ID: 4093854
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of oral antidiabetic drugs.
    AIMAN R; CHAUDHARY N
    Br J Pharmacol Chemother; 1959 Sep; 14(3):377-9. PubMed ID: 13792172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiating the diabetogenic effect of alloxan by N-sulphonyl-N-butylurea (BZ-55).
    MOSINGER B; BRAUN T
    Experientia; 1959 Aug; 15():317-8. PubMed ID: 14424566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative evaluation of the effect of diaboral and insulin on the secretory function of the pancreas in dogs under normal conditions and in alloxan diabetes].
    Rudyĭ RV
    Farmakol Toksikol; 1968; 31(1):80-3. PubMed ID: 5675356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.